27
Feb
Sanofi Consumer Healthcare India Limited (BSE: 544250 | NSE: SANOFICONR) has reported a strong set of numbers for the fourth quarter and full year ended December 31, 2025, driven by robust domestic growth and a sharp rise in exports. The company posted Q4 revenue of ₹2,510 million, up 47% year-on-year. Domestic sales grew 23%, supported by the relaunch of recalled products, while export sales surged 9.3 times on a low base. Profit after tax rose 50% to ₹665 million during the quarter. For the full year FY25, revenue stood at ₹8,784 million, marking a 21% growth over the previous year.…
